GlassScriptPhysician profile
Alan Bass
NPI 1649260563
$1,606.97
in general payments reported to CMS, 2019-2025
10 companies · $75.22 in 2025
The $75.22 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.05 · 2020: $220 · 2021: $143 · 2022: $262 · 2023: $468 · 2024: $367 · 2025: $75.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $279.41 | 2021-2024 | Eterna |
| Medtronic, INC. | $255.58 | 2022-2025 | Closurefast |
| Cardiovascular Systems INC. | $255.29 | 2020-2022 | |
| Vaporox, INC. | $167.00 | 2023 | Vht-200 Wound Treatment System |
| Horizon Therapeutics Plc | $124.42 | 2023 | Krystexxa |
| Amgen INC. | $124.09 | 2024 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $123.67 | 2023 | Nuzyra |
| Advanced Oxygen Therapy INC. | $106.48 | 2024 | Topical Oxygen Chamber For Extremities |
| Boston Scientific Corporation | $98.98 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $72.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.